| - GRCh37:
- ChrMT:578
- GRCh38:
- ChrMT:578
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Likely pathogenic (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:579
- GRCh38:
- ChrMT:579
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:583
- GRCh38:
- ChrMT:583
| MT-TF | | Mitochondrial disease | Uncertain significance (Oct 10, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- ChrMT:586
- GRCh38:
- ChrMT:586
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Pathogenic (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:588
- GRCh38:
- ChrMT:588
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:590
- GRCh38:
- ChrMT:590
| MT-TF | | Mitochondrial disease | Pathogenic (Oct 1, 2019) | no assertion criteria provided |
| - GRCh37:
- ChrMT:591
- GRCh38:
- ChrMT:591
| MT-TF | | Hypokalemia, Hypomagnesemia, Nephropathy, chronic tubulointerstitial
| Pathogenic/Likely pathogenic (Jul 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- ChrMT:592
- GRCh38:
- ChrMT:592
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:593-594
- GRCh38:
- ChrMT:593-594
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:593
- GRCh38:
- ChrMT:593
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:595
- GRCh38:
- ChrMT:595
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Likely benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:595
- GRCh38:
- ChrMT:595
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Likely benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:596
- GRCh38:
- ChrMT:596
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:597-598
- GRCh38:
- ChrMT:597-598
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Likely benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:597
- GRCh38:
- ChrMT:597
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:603
- GRCh38:
- ChrMT:603
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Likely benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:606
- GRCh38:
- ChrMT:606
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:608
- GRCh38:
- ChrMT:608
| MT-TF | | not specified | Uncertain significance (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:611
- GRCh38:
- ChrMT:611
| MT-TF | | MERRF syndrome | Pathogenic (Sep 25, 2007) | no assertion criteria provided |
| - GRCh37:
- ChrMT:616
- GRCh38:
- ChrMT:616
| MT-TF | | Epilepsy, mitochondrial | Pathogenic (Feb 9, 2010) | no assertion criteria provided |
| - GRCh37:
- ChrMT:616
- GRCh38:
- ChrMT:616
| MT-TF | | Mitochondrial disease | Likely pathogenic (Jun 30, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- ChrMT:618
- GRCh38:
- ChrMT:618
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke, Mitochondrial disease | Pathogenic/Likely pathogenic (May 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- ChrMT:619
- GRCh38:
- ChrMT:619
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:621
- GRCh38:
- ChrMT:621
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Likely benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:622
- GRCh38:
- ChrMT:622
| MT-TF | | Mitochondrial disease | Pathogenic (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:624
- GRCh38:
- ChrMT:624
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:628
- GRCh38:
- ChrMT:628
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:629
- GRCh38:
- ChrMT:629
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Likely benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:629
- GRCh38:
- ChrMT:629
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:630
- GRCh38:
- ChrMT:630
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:633
- GRCh38:
- ChrMT:633
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:634
- GRCh38:
- ChrMT:634
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:634
- GRCh38:
- ChrMT:634
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:635
- GRCh38:
- ChrMT:635
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:636
- GRCh38:
- ChrMT:636
| MT-TF | | not specified | Uncertain significance (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:643
- GRCh38:
- ChrMT:643
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke, Hypokalemia, Hypomagnesemia, Chronic kidney disease | Uncertain significance (Jul 7, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- ChrMT:644
- GRCh38:
- ChrMT:644
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:647
- GRCh38:
- ChrMT:647
| MT-TF | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |